[go: up one dir, main page]

DK3269809T3 - MODIFICERET AMINOACYL-tRNA-SYNTETASE OG ANVENDELSE DERAF - Google Patents

MODIFICERET AMINOACYL-tRNA-SYNTETASE OG ANVENDELSE DERAF Download PDF

Info

Publication number
DK3269809T3
DK3269809T3 DK16764874.0T DK16764874T DK3269809T3 DK 3269809 T3 DK3269809 T3 DK 3269809T3 DK 16764874 T DK16764874 T DK 16764874T DK 3269809 T3 DK3269809 T3 DK 3269809T3
Authority
DK
Denmark
Prior art keywords
trna synthetase
modified aminoacyl
aminoacyl
modified
trna
Prior art date
Application number
DK16764874.0T
Other languages
English (en)
Inventor
Atsushi Ohta
Yusuke Yamagishi
Atsushi Matsuo
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK3269809T3 publication Critical patent/DK3269809T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
DK16764874.0T 2015-03-13 2016-03-11 MODIFICERET AMINOACYL-tRNA-SYNTETASE OG ANVENDELSE DERAF DK3269809T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015051202 2015-03-13
PCT/JP2016/057707 WO2016148044A1 (ja) 2015-03-13 2016-03-11 改変アミノアシルtRNA合成酵素およびその用途

Publications (1)

Publication Number Publication Date
DK3269809T3 true DK3269809T3 (da) 2022-09-12

Family

ID=56918843

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16764874.0T DK3269809T3 (da) 2015-03-13 2016-03-11 MODIFICERET AMINOACYL-tRNA-SYNTETASE OG ANVENDELSE DERAF

Country Status (6)

Country Link
US (3) US10815489B2 (da)
EP (2) EP4166664A1 (da)
JP (3) JP7020910B2 (da)
DK (1) DK3269809T3 (da)
HU (1) HUE059925T2 (da)
WO (1) WO2016148044A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI640541B (zh) 2011-12-28 2018-11-11 中外製藥股份有限公司 Peptide compound having an annular portion and pharmaceutical composition thereof
HUE059925T2 (hu) 2015-03-13 2023-01-28 Chugai Pharmaceutical Co Ltd Módosított aminoacil-tRNS-szintetáz és alkalmazása
JP7187323B2 (ja) 2017-01-31 2022-12-12 中外製薬株式会社 無細胞翻訳系におけるペプチドの合成方法
JP7232758B2 (ja) 2017-06-09 2023-03-06 中外製薬株式会社 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ
CN110799520B (zh) 2017-06-09 2024-07-12 中外制药株式会社 用于合成含有n-取代氨基酸的肽的方法
US11492369B2 (en) 2017-12-15 2022-11-08 Chugai Seiyaku Kabushiki Kaisha Method for producing peptide, and method for processing bases
WO2019193416A1 (en) * 2018-04-03 2019-10-10 The University Of Queensland Oligonucleotide-mediated sense codon reassignment
EP3804759A4 (en) * 2018-06-06 2022-07-20 Osaka University METHODS OF TREATMENT OF DANDRUFF OR PREVENTION OF GNASE 1 SECONDARY DISEASES
CN112969683B (zh) 2018-11-07 2024-05-14 中外制药株式会社 O-取代的丝氨酸衍生物制备方法
KR20210098476A (ko) 2018-11-30 2021-08-10 추가이 세이야쿠 가부시키가이샤 펩티드 화합물 또는 아마이드 화합물의 탈보호법 및 고상 반응에 있어서의 탈수지 방법, 및 펩티드 화합물의 제조 방법
CN113454058B (zh) 2018-12-12 2024-03-22 中外制药株式会社 具有能形成分子内氢键的官能团的氨基酸、包含该氨基酸的肽化合物、及其制备方法
WO2020189540A1 (ja) 2019-03-15 2020-09-24 中外製薬株式会社 芳香族アミノ酸誘導体の製造方法
US20220325269A1 (en) * 2019-08-08 2022-10-13 Brickbio, Inc. Aminoacyl-trna synthetases and cell lines for site-specific incorporation of unnatural amino acids
KR102368948B1 (ko) 2019-11-07 2022-03-02 추가이 세이야쿠 가부시키가이샤 Kras 저해 작용을 갖는 환상 펩티드 화합물
WO2021117848A1 (ja) 2019-12-12 2021-06-17 中外製薬株式会社 非天然アミノ酸を含むペプチドの製造方法
JPWO2022138892A1 (da) 2020-12-25 2022-06-30
AU2023264918A1 (en) 2022-05-06 2025-01-09 Chugai Seiyaku Kabushiki Kaisha Cyclic compound having selective kras inhibitory effect on hras and nras
CA3268707A1 (en) * 2022-09-28 2024-04-04 Massachusetts Institute Of Technology EVOLUTION OF FLUOROGENEOUS SENSORS
CN120380162A (zh) 2022-12-12 2025-07-25 中外制药株式会社 包括用于翻译在特定位置处具有氧原子的氨基酸的步骤的肽生产方法
WO2024214303A1 (ja) 2023-04-14 2024-10-17 中外製薬株式会社 複数種類の標的分子との複合体を形成し得る目的分子のスクリーニング方法、及び当該スクリーニング方法を含む目的分子の製造方法

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159747A (en) 1981-03-27 1982-10-01 Kenji Okawa Synthesis of amino acid derivative
JPS60169451A (ja) 1984-02-13 1985-09-02 Mitsui Toatsu Chem Inc L−フエニルアラニンの分離精製法
FR2583432B1 (fr) 1985-06-13 1988-11-04 Inst Francais Du Petrole Procede de production enzymatique de l-a-aminoacides a partir d'a-cetoacides
ES8607214A1 (es) 1985-10-16 1986-06-01 Gema Sa Procedimiento enzimatico de resolucion de n-fenilacetil-ami-nocompuestos y purificacion de sus isomeros opticamente ac- tivos
US4859736A (en) 1987-03-30 1989-08-22 Ciba-Geigy Corporation Synthetic polystyrene resin and its use in solid phase peptide synthesis
DE3733198A1 (de) 1987-10-01 1989-04-13 Kernforschungsanlage Juelich Enzymatisches verfahren zur herstellung von dipeptiden
JPH0681759B2 (ja) 1988-03-31 1994-10-19 信越化学工業株式会社 ポリペプチドの製造方法
US6258558B1 (en) 1997-01-21 2001-07-10 The General Hospital Corporation Method for selection of proteins using RNA-protein fusions
US20020068301A1 (en) 1997-05-28 2002-06-06 Hung-Sen Lai Cyclic peptide libraries and methods of use thereof to identify binding motifs
JP4502293B2 (ja) 1999-06-04 2010-07-14 長瀬産業株式会社 軸不斉を有する光学活性な4級アンモニウム塩、その製法およびα−アミノ酸誘導体の不斉合成への応用
DE19942624A1 (de) 1999-08-28 2001-03-08 Chemotopix Gmbh Verfahren zur Herstellung von zyklischen Peptidomimetika
IL151935A0 (en) 2000-04-19 2003-04-10 Schering Corp Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
EP1277755A4 (en) 2000-04-21 2006-01-11 Nagase & Co Ltd OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT BY AXIAL ASYMMETRY, METHOD FOR THE PRODUCTION THEREOF, AND THEIR APPLICATION IN THE ASYMMETRIC SYNTHESIS OF ALPHA-AMINO-ACID DERIVATIVES
IL158419A0 (en) 2001-04-19 2004-05-12 Scripps Research Inst Methods and composition for the production of orthoganal trna-aminoacyl trna synthetase pairs
CA2452818C (en) 2001-08-01 2010-06-29 Japan Science And Technology Agency Tyrosyl-trna synthetase variants
US7288372B2 (en) 2002-01-17 2007-10-30 Ambergen, Inc. Methods for the preparation of chemically misaminoacylated tRNA via protective groups
AU2003225085A1 (en) 2002-04-19 2003-11-03 California Institute Of Technology Unnatural amino acid containing display libraries
JP4490663B2 (ja) 2003-09-22 2010-06-30 株式会社東京大学Tlo イソロイシンtRNA(tRNAIle)のライシジン合成酵素(TilS)としてのmesJ遺伝子産物及びその相同性遺伝子(COG0037)
WO2005063791A2 (en) 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Process for peptide synthesis using a reduced amount of deprotection agent
US20080221303A1 (en) 2004-02-18 2008-09-11 Jehoshua Katzhendler Method for the Preparation of Peptide-Oligonucleotide Conjugates
US8188260B2 (en) 2005-12-06 2012-05-29 The University Of Tokyo Versatile acylation catalytic RNAs and uses thereof
ES2504521T3 (es) 2006-03-03 2014-10-08 California Institute Of Technology Incorporación específica del sitio de aminoácidos en moléculas
JP5119437B2 (ja) 2006-03-06 2013-01-16 国立大学法人東京工業大学 機能性非天然型タンパク質の製造法、及び当該タンパク質の部位特異的修飾・固定化法
WO2007120614A2 (en) 2006-04-11 2007-10-25 Sloan-Kettering Institute For Cancer Research Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation
JP2007319064A (ja) 2006-05-31 2007-12-13 Japan Science & Technology Agency 修飾化アミノ酸を部位特異的に導入したタンパク質を発現させる方法
JP5200241B2 (ja) 2006-11-17 2013-06-05 国立大学法人 東京大学 N末端に非天然骨格をもつポリペプチドの翻訳合成とその応用
US8227209B2 (en) 2007-03-06 2012-07-24 Tokyo Institute Of Technology Process for producing functional non-naturally occurring proteins, and method for site-specific modification and immobilization of the proteins
WO2008117833A1 (ja) 2007-03-26 2008-10-02 The University Of Tokyo 環状ペプチド化合物の合成方法
BRPI0817212A2 (pt) * 2007-09-20 2014-10-14 Riken Pirrolisil-trna sintetase mutante, e método para a produção de proteína tendo aminoácido não-natural integrado nela por sua utilização
JP2009096791A (ja) 2007-09-26 2009-05-07 Kaneka Corp アミノ酸の製造方法
EP2177533A1 (en) 2008-10-09 2010-04-21 TU München Multiple N-methylated cyclic hexapeptides for treatment of neurogenic inflammation
TWI468375B (zh) 2008-10-27 2015-01-11 Janssen Pharmaceutica Nv 製備經保護之l-丙胺酸衍生物之方法
WO2010053050A1 (ja) 2008-11-04 2010-05-14 株式会社カネカ O-アルキルセリンおよびn-ベンジル-o-アルキルセリンの製造法
JP2012510486A (ja) 2008-12-03 2012-05-10 エフ.ホフマン−ラ ロシュ アーゲー 治療用ペプチドの製造方法
EP2424888A2 (en) 2009-05-01 2012-03-07 F. Hoffmann-La Roche AG Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20120208720A1 (en) 2009-10-22 2012-08-16 Kenji Kashiwagi Rapid display method in translational synthesis of peptide
GB0919194D0 (en) 2009-11-02 2009-12-16 Lytix Biopharma As Compounds
US20110118314A1 (en) 2009-11-16 2011-05-19 Weiya Yun Piperidine analogs as glycogen synthase activators
JP2011139667A (ja) 2010-01-07 2011-07-21 Tottori Univ プロリンおよびβ−アラニンをN末端に有するジペプチド、及びその環化ジペプチドの酵素合成法
EP2380596A1 (en) 2010-04-20 2011-10-26 Technische Universität München Cyclopentapeptide derivatives and uses thereof
JP5725467B2 (ja) 2010-08-27 2015-05-27 国立大学法人 東京大学 新規人工翻訳合成系
JP5818237B2 (ja) 2010-09-09 2015-11-18 国立大学法人 東京大学 N−メチルアミノ酸およびその他の特殊アミノ酸を含む特殊ペプチド化合物ライブラリーの翻訳構築と活性種探索法
JP6206943B2 (ja) 2010-12-03 2017-10-04 国立大学法人 東京大学 ペプチドライブラリーの製造方法、ペプチドライブラリー、及びスクリーニング方法
JP6239979B2 (ja) 2011-03-04 2017-11-29 ニューヨーク・ユニバーシティ Rasの調節因子としての水素結合代替大環状分子
US9133245B2 (en) 2011-06-13 2015-09-15 Trustees Of Boston College Cyclic lactadherin peptide mimetics and their uses
WO2013009868A1 (en) 2011-07-11 2013-01-17 Yale University Compositions and methods for making selenocysteine containing polypeptides
TWI640541B (zh) 2011-12-28 2018-11-11 中外製藥股份有限公司 Peptide compound having an annular portion and pharmaceutical composition thereof
GB201215538D0 (en) 2012-08-31 2012-10-17 Stetsenko Dmitry Method and compositions for removing acid-labile protecting groups
JP6440055B2 (ja) 2013-05-10 2018-12-19 国立大学法人 東京大学 ペプチドライブラリの製造方法、ペプチドライブラリ、及びスクリーニング方法
JP6571650B2 (ja) 2013-08-05 2019-09-04 メディミューン リミテッド アミノ酸誘導体
JP6357154B2 (ja) 2013-08-05 2018-07-11 国立大学法人 東京大学 荷電性非タンパク質性アミノ酸含有ペプチドの製造方法
US20170022254A1 (en) 2014-04-08 2017-01-26 Novartis Ag Novel Aldehyde Acetal Based Processes for the Manufacture of Macrocyclic Depsipeptides and New Intermediates
US20170112896A1 (en) 2014-05-20 2017-04-27 Ohio State Innovation Foundation Small molecule rac or rho inhibitors
US10919938B2 (en) 2014-06-06 2021-02-16 Technische Universität München Modified cyclopentapeptides and uses thereof
WO2016115168A1 (en) 2015-01-12 2016-07-21 Synthorx, Inc. Incorporation of unnatural nucleotides and methods thereof
HUE059925T2 (hu) 2015-03-13 2023-01-28 Chugai Pharmaceutical Co Ltd Módosított aminoacil-tRNS-szintetáz és alkalmazása
JP2018509172A (ja) 2015-03-27 2018-04-05 ザ ユニバーシティ オブ クィーンズランド タンパク質への非天然アミノ酸組込みのためのプラットフォーム
JP2017043615A (ja) 2015-08-27 2017-03-02 塩野義製薬株式会社 環状ペプチドの膜透過性および/または代謝安定性を改善するシクロプロパンアミノ酸ユニット
US9913245B2 (en) 2015-10-23 2018-03-06 Qualcomm Incorporated Multi-subscriber identity module (SIM) call setup
US10662220B2 (en) 2016-02-04 2020-05-26 The Johns Hopkins University Synthesis and composition of rapafucin libraries
US20190338050A1 (en) 2016-03-03 2019-11-07 Chugai Seiyaku Kabushiki8 Kaisha Production method for noncyclic peptide-nucleic acid complex having, at n-terminal, amino acid with thiol group near amino group, library thereof, and cyclic peptide-nucleic acid complex library derived from same
WO2017181061A1 (en) 2016-04-15 2017-10-19 Ra Pharmaceuticals, Inc. Ras binding peptides and methods of use
IT201600122363A1 (it) 2016-12-02 2018-06-02 Dolores Fregona Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi in oncologia
JP7187323B2 (ja) 2017-01-31 2022-12-12 中外製薬株式会社 無細胞翻訳系におけるペプチドの合成方法
CN110799520B (zh) 2017-06-09 2024-07-12 中外制药株式会社 用于合成含有n-取代氨基酸的肽的方法
JP7232758B2 (ja) 2017-06-09 2023-03-06 中外製薬株式会社 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ
US11492369B2 (en) 2017-12-15 2022-11-08 Chugai Seiyaku Kabushiki Kaisha Method for producing peptide, and method for processing bases
CN112969683B (zh) 2018-11-07 2024-05-14 中外制药株式会社 O-取代的丝氨酸衍生物制备方法
KR20210098476A (ko) 2018-11-30 2021-08-10 추가이 세이야쿠 가부시키가이샤 펩티드 화합물 또는 아마이드 화합물의 탈보호법 및 고상 반응에 있어서의 탈수지 방법, 및 펩티드 화합물의 제조 방법
CN113454058B (zh) 2018-12-12 2024-03-22 中外制药株式会社 具有能形成分子内氢键的官能团的氨基酸、包含该氨基酸的肽化合物、及其制备方法
CN119080856A (zh) 2018-12-26 2024-12-06 中外制药株式会社 用于密码子扩展的突变tRNA
WO2020189540A1 (ja) 2019-03-15 2020-09-24 中外製薬株式会社 芳香族アミノ酸誘導体の製造方法
KR102368948B1 (ko) 2019-11-07 2022-03-02 추가이 세이야쿠 가부시키가이샤 Kras 저해 작용을 갖는 환상 펩티드 화합물
WO2021117848A1 (ja) 2019-12-12 2021-06-17 中外製薬株式会社 非天然アミノ酸を含むペプチドの製造方法
CN114641569A (zh) 2019-12-26 2022-06-17 中外制药株式会社 翻译用组合物及肽的制备方法
JPWO2021261577A1 (da) 2020-06-25 2021-12-30
EP4309741A4 (en) 2021-05-07 2025-05-14 Chugai Seiyaku Kabushiki Kaisha CYCLIC COMPOUND WITH SELECTIVE INHIBITORY FOR KRAs BUT NOT FOR HRAS AND NRAS

Also Published As

Publication number Publication date
US12163134B2 (en) 2024-12-10
WO2016148044A1 (ja) 2016-09-22
EP3269809A4 (en) 2018-12-05
EP3269809B1 (en) 2022-07-27
JP7020910B2 (ja) 2022-02-16
US20250051784A1 (en) 2025-02-13
EP3269809A1 (en) 2018-01-17
JPWO2016148044A1 (ja) 2017-12-28
EP4166664A1 (en) 2023-04-19
JP7661399B2 (ja) 2025-04-14
JP2023116605A (ja) 2023-08-22
US20210087572A1 (en) 2021-03-25
US20180127761A1 (en) 2018-05-10
HUE059925T2 (hu) 2023-01-28
US10815489B2 (en) 2020-10-27
JP2022061999A (ja) 2022-04-19
JP7292442B2 (ja) 2023-06-16

Similar Documents

Publication Publication Date Title
DK3269809T3 (da) MODIFICERET AMINOACYL-tRNA-SYNTETASE OG ANVENDELSE DERAF
IL280863A (en) Autotaxin inhibitors and uses thereof
DK3448386T3 (da) Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf
DK3452463T3 (da) Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf
DK3302431T3 (da) Taxanpartikler og anvendelse deraf
DK3268470T3 (da) Transposasepolypeptider og anvendelser deraf
DK3333191T3 (da) Anti-C10ORF54-antistoffer og anvendelser deraf
DK3157552T3 (da) Syntac-polypeptider og anvendelser deraf
DK3126388T3 (da) Anti-EGFRvIII-antistoffer og anvendelser deraf
DK3283106T3 (da) Terapeutiske antistoffer og anvendelser deraf
DK3559227T3 (da) Proteasevarianter og anvendelser deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3368534T3 (da) Valbenazin-ditosylat og polymorfer deraf
DK3099172T3 (da) Modificeret biologisk bekæmpelsesmiddel og anvendelser deraf
DK3331877T3 (da) Pyrazolpyrimidinderivat og anvendelser deraf
DK3532499T3 (da) ANTI-IL-33-antistoffer og anvendelser deraf
DK3236991T3 (da) Fgf21-derivater og anvendelser deraf
DK3402821T5 (da) Psma-bindende antistof og anvendelser deraf
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf
DK3368655T3 (da) Forbedret proteinekspression og fremgangsmåder dertil
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
DK3498292T3 (da) Uspa2-proteinkonstruktioner og anvendelser deraf
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3100050T3 (da) Immobiliserede proteiner og anvendelse deraf